Jazz Pharmaceuticals
JAZZ
JAZZ
306 hedge funds and large institutions have $7.59B invested in Jazz Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 88 increasing their positions, 122 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
4% more funds holding
Funds holding: 294 → 306 (+12)
0.53% more ownership
Funds ownership: 86.99% → 87.52% (+0.53%)
28% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 122
Holders
306
Holding in Top 10
11
Calls
$111M
Puts
$57.1M
Top Buyers
| 1 | +$452M | |
| 2 | +$109M | |
| 3 | +$72.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$72M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$68.1M |
Top Sellers
| 1 | -$92.1M | |
| 2 | -$60.4M | |
| 3 | -$58M | |
| 4 |
CCM
Cadian Capital Management
New York
|
-$46.7M |
| 5 |
Two Sigma Investments
New York
|
-$39.3M |